News
Connect with Canadian and international experts in the objective assessment and evaluation of health technologies this April in Toronto, Ontario. We have added an additional full day of thought-provoking and interactive workshops to the program for a total of four days of education, information sharing, and networking.
Please note: Anyone can...
Today, CADTH has issued final recommendations for:
glucagon (Baqsimi)
Indications: Severe hypoglycemic reactions
Recommendation: Reimburse with clinical criteria and/or conditions
For more information
Today, CADTH has issued final recommendations for:
Trastuzumab Emtansine (Kadcyla) for Early Breast Cancer (EBC)
Funding Request: For the adjuvant treatment of patients with HER2-positive early breast cancer, who have residual disease, after pre-operative systemic treatment. KADCYLA should be continued for 14 cycles or until disease progressio...
A new project on Early Identification of Stroke is now available for feedback from all interested stakeholders.
Early Identification of Stroke
Call for Feedback: 2020-01-17
Feedback Due By: 2020-01-31
Consultation Document: Horizon Scanning Report
Product Type: Issues in Emerging Health Technologies
Submit Feedback
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
